Safety first: Profiling adverse events in cancer drug therapies
Advancements in cancer drug therapies have revolutionised oncology, turning terminal diagnoses into manageable conditions.
However, these therapies often bring adverse events that can significantly impact patients’ quality of life and outcomes. For pharma professionals, understanding these adverse events, how they can be managed, and the role of patient-clinician interactions is vital in improving the patient journey.
In this article, we explore:
- The typical adverse events that accompany certain cancer treatments
- What different strategies that exist for their management
- What digital solutions are available to assist in managing these events
- The implications for patients, healthcare systems and pharmaceutical companies
